洁特生物
(688026)
| 流通市值：29.50亿 | | | 总市值：29.50亿 |
| 流通股本：1.40亿 | | | 总股本：1.40亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 311,845,984.93 | 325,278,853.16 | 347,751,720.7 | 438,226,897.19 |
| 交易性金融资产 | 144,054,500 | 140,238,219.18 | 50,238,219.18 | 50,000,000 |
| 应收票据及应收账款 | 125,392,510.71 | 108,006,998 | 136,176,255.52 | 122,505,340.25 |
| 应收账款 | 125,392,510.71 | 108,006,998 | 136,176,255.52 | 122,505,340.25 |
| 预付款项 | 14,202,129.05 | 30,783,279.83 | 19,037,788.67 | 7,534,130.99 |
| 其他应收款合计 | 15,742,137.62 | 11,482,684.07 | 2,437,462.23 | 15,653,577.84 |
| 存货 | 161,067,223.13 | 147,865,835.54 | 133,517,177.16 | 140,915,625.47 |
| 其他流动资产 | 19,276,407.51 | 21,879,568.67 | 120,375,253.17 | 16,961,404.51 |
| 流动资产合计 | 791,580,892.95 | 785,535,438.45 | 809,533,876.63 | 791,796,976.25 |
| 非流动资产: | | | | |
| 长期股权投资 | 11,545,173.49 | 11,091,481.18 | 10,994,619.56 | 36,768,097.83 |
| 其他权益工具投资 | 33,959,301.72 | 34,605,557.16 | 34,710,831.19 | 29,483,928.8 |
| 投资性房地产 | 184,460,562.45 | 188,866,879.1 | 187,829,073.74 | 183,454,085.47 |
| 固定资产 | 579,497,197.35 | 549,480,261.77 | 559,073,276.18 | 563,371,074.21 |
| 在建工程 | 10,076,845.73 | 43,498,848.98 | 27,609,335.7 | 1,858,988.93 |
| 使用权资产 | 1,044,261.44 | 1,495,289.92 | 1,700,509.75 | 863,140.75 |
| 无形资产 | 58,646,842.75 | 59,194,682.42 | 52,280,033.77 | 53,359,892.66 |
| 递延所得税资产 | 650,940.25 | 97,260.03 | 19,586.68 | 7,384,151.37 |
| 其他非流动资产 | 61,510,507.2 | 42,503,431.79 | 57,576,955.57 | 79,885,960.23 |
| 非流动资产合计 | 941,391,632.38 | 930,833,692.35 | 931,794,222.14 | 956,429,320.25 |
| 资产平衡项目 | 0 | -0.01 | 0 | 0 |
| 资产总计 | 1,732,972,525.33 | 1,716,369,130.79 | 1,741,328,098.77 | 1,748,226,296.5 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 40,695,991.63 | 32,340,586.19 | 39,674,806.19 | 44,468,967.44 |
| 应付账款 | 40,695,991.63 | 32,340,586.19 | 39,674,806.19 | 44,468,967.44 |
| 预收款项 | 4,745,285.35 | 5,224,900.55 | 5,472,667.77 | 5,404,774.36 |
| 合同负债 | 15,109,546.67 | 17,282,180.43 | 17,647,992.07 | 16,180,257.6 |
| 应付职工薪酬 | 14,195,518.28 | 22,054,725.13 | 21,915,081.6 | 14,064,483.87 |
| 应交税费 | 6,117,064.39 | 3,360,672.91 | 10,047,550.71 | 7,245,764.02 |
| 其他应付款合计 | 19,819,534.78 | 9,510,130.21 | 8,160,955.18 | 10,815,372.01 |
| 应付股利 | 10,050,247.4 | - | - | - |
| 一年内到期的非流动负债 | 1,217,717.3 | 6,443,730.91 | 4,494,003.91 | 2,343,163.9 |
| 其他流动负债 | 193,381.98 | 239,317.44 | 169,512.87 | 161,531.02 |
| 流动负债平衡项目 | 0 | -0.01 | 0 | 0 |
| 流动负债合计 | 102,094,040.38 | 96,456,243.76 | 107,582,570.3 | 100,684,314.22 |
| 非流动负债: | | | | |
| 应付债券 | 393,710,777.52 | 388,061,005.87 | 382,476,796.67 | 376,816,888.64 |
| 租赁负债 | 400,371.92 | 279,710.87 | 422,997.98 | 49,896.34 |
| 递延收益 | 27,037,389.03 | 25,498,281.06 | 23,982,220.09 | 25,076,126.62 |
| 递延所得税负债 | 1,547,906.37 | 3,274,539 | 1,703,816.37 | 35,283.19 |
| 非流动负债合计 | 422,696,444.84 | 417,113,536.8 | 408,585,831.11 | 401,978,194.79 |
| 负债合计 | 524,790,485.22 | 513,569,780.56 | 516,168,401.41 | 502,662,509.01 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 140,364,427 | 140,364,427 | 140,364,345 | 140,363,220 |
| 其他权益工具 | 109,276,390.68 | 109,276,390.68 | 109,277,384.11 | 129,905,536.4 |
| 资本公积 | 412,929,919.94 | 412,929,919.94 | 413,624,303.64 | 413,561,970.81 |
| 减:库存股 | 59,999,308.31 | 48,748,006.81 | 30,000,946.05 | 30,000,946.05 |
| 其他综合收益 | 894,714.67 | 1,444,031.79 | 1,533,514.72 | 1,327,027.35 |
| 盈余公积 | 70,182,172.5 | 70,182,172.5 | 70,182,172.5 | 68,949,063.29 |
| 未分配利润 | 522,087,031.38 | 507,097,511.04 | 511,320,692.28 | 513,013,576.86 |
| 归属于母公司股东权益合计 | 1,195,735,347.86 | 1,192,546,446.14 | 1,216,301,466.2 | 1,237,119,448.66 |
| 少数股东权益 | 12,446,692.25 | 10,252,904.09 | 8,858,231.16 | 8,444,338.83 |
| 股东权益合计 | 1,208,182,040.11 | 1,202,799,350.23 | 1,225,159,697.36 | 1,245,563,787.49 |
| 负债和股东权益合计 | 1,732,972,525.33 | 1,716,369,130.79 | 1,741,328,098.77 | 1,748,226,296.5 |
| 公告日期 | 2026-08-31 | 2026-04-30 | 2026-04-30 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |